SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Galaxy Digital, Inc. engages in digital assets and data center infrastructure, delivering solutions that accelerate progress in finance and artificial intelligence. It operates through the following segments: Digital Assets, Data Centers, and Treasury and Corporate. The digital assets segment offers institutional access to trading, advisory, asset management, staking, self-custody, and tokenization technology. The Data Centers segment competes with a range of infrastructure providers that are building or repurposing facilities to support the rapidly growing demand for AI and compute-intensive workloads. The Treasury and Corporate segment includes the company’s proprietary trading and mining activities, as well as the company’s principal investments and related gains and losses. The company was founded by Michael Novogratz in 2018 and is headquartered in New York, NY.

Galaxy Digital Inc. - Ordinary Shares - Class A

Galaxy Digital is trending as investors focus on its pivot toward AI infrastructure, specifically the development of its large-scale Helios data center in Texas. Community members are actively debating the company's dual identity as a crypto and data center play, with many seeking greater transparency and faster tenant announcements from management to justify higher valuations.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckin Coffee is trending as retail investors express intense frustration over stagnant price action and lack of communication regarding a potential relisting, despite the company's aggressive store expansion and recent announcement of a share buyback program. The community remains deeply divided between long-term 'longs' who view the current valuation as disconnected from fundamental growth and frustrated traders who are increasingly rotating capital into higher-momentum sectors.

Keel Infrastructure Corp. engages in building artificial intelligence focused data centers and energy assets. It focuses on infrastructure and energy required to support high-performance computing and artificial intelligence workloads. The company was founded on April 1, 2026 and is headquartered in New York, NY.

Keel Infrastructure Corp.

Keel Infrastructure Corp

Keel Infrastructure Corp is trending amid heavy speculation about a potential data center partnership with Amazon Web Services, fueled by recent job postings and board connections. While the stock is facing volatility following a capital raise and broader market pressure, community members remain focused on the company's expansion plans, institutional activity, and the anticipation of signed lease agreements.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics is trending as investors focus on a strong intellectual property milestone following the submission of the MIPLYFFA patent to the FDA's Orange Book, securing exclusivity through 2041. The community is actively debating the company's valuation, upcoming European regulatory decisions, and persistent rumors of a potential buyout, all while keeping a close watch on analyst price target upgrades.

AmpliTech Group, Inc. engages in the design, development, and manufacture of radio frequency components. It offers signal processing components for satellite and 5G communications networks, defense, space, and other commercial applications. Its products include amplifiers, passive components, mechanical drawings, monolithic microwave integrated circuit, and 5G. The company was founded by Fawad Maqbool in 2002 and is headquartered in Hauppauge, NY.

Amplitech Group Inc

Amplitech Group is trending as investors track its role as a key infrastructure provider across high-growth sectors including 5G, satellite communications, defense, and quantum computing. Community discussions are heavily focused on the company's recent regulatory certifications, its pipeline of letters of intent with mobile network operators, and its perceived undervaluation relative to its aggressive revenue growth targets.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is trending as investors weigh the company's upcoming WWDC keynote, which is widely seen as a pivotal reset for its AI strategy and the potential final major product announcement under Tim Cook. Community sentiment remains polarized, with some traders debating whether current valuation premiums are justified by a 'flight to safety' narrative or if the stock is overextended ahead of the event.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is facing intense investor frustration as the stock struggles with a sustained sell-off, with many market participants pointing to a perceived loss of momentum in the AI race compared to its peers. The community is actively debating the stock's long-term value versus the current technical weakness, while traders closely monitor its struggle to hold key support levels amid broader market rotation and skepticism over capital expenditure.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is experiencing significant community division as investors weigh long-term dividend stability and promising pipeline updatesincluding progress on weight loss and oncology assetsagainst ongoing frustration with stagnant share performance compared to the broader tech sector. While some retail shareholders view the current valuation as a deep-value accumulation opportunity, others are aggressively critical of management's leadership and the stock's persistent inability to sustain upward momentum.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending as the community scrutinizes a polarizing executive compensation proposal and discusses the company's long-term value proposition. Investors are actively debating the timing of potential partnerships, the impact of heavy short interest, and the significance of recent regulatory updates regarding their vaccine technology.

Nurix Therapeutics, Inc. is a clinical stage biopharmaceutical company. It engages in the business of discovering, developing, and commercializing innovative small molecules and antibody therapies based on the modulation of cellular protein levels as a novel treatment approach for cancer, inflammatory conditions, and other challenging diseases. The company was founded by John Kuriyan, Michael Rapé, and Arthur Weiss in 2009 and is headquartered in Brisbane, CA.

Nurix Therapeutics Inc

Nurix Therapeutics is gaining momentum following a lucrative collaboration deal with Roche to co-develop a promising cancer drug, a move that provides significant capital and market validation for its protein degradation platform. Community members are actively debating the company's valuation relative to its cash reserves, the strategic impact of the Roche partnership on its long-term growth, and the potential for a future acquisition by major pharmaceutical players.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
